OATAO - Open Archive Toulouse Archive Ouverte Open Access Week

US-guided percutaneous release of the first extensor tendon compartment using a 21-gauge needle in de Quervain’s disease: a prospective study of 35 cases

Lapègue, Franck and André, Aymeric and Pasquier Bernachot, Etienne and Akakpo, Ezin Jocelyn and Laumonerie, Pierre and Chiavassa-Gandois, Hélène and Lasfar, Omar and Borel, Christophe and Brunet, Marine and Constans, Olivia and Basselerie, Hubert and Sans, Nicolas and Faruch-Bilfeld, Marie US-guided percutaneous release of the first extensor tendon compartment using a 21-gauge needle in de Quervain’s disease: a prospective study of 35 cases. (2018) European Radiology, 28 (9). 3977-3985. ISSN 0938-7994

[img]
Preview
(Document in English)

PDF (Author's version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
5MB

Official URL: https://doi.org/10.1007/s00330-018-5387-1

Abstract

PURPOSE: To evaluate the efficacy of ultrasonography-guided percutaneous treatment of de Quervain tenosynovitis with the combination of a corticosteroid injection and release of the retinaculum of the first extensor compartment tendons with a 21-gauge needle. MATERIALS AND METHODS: The first part of our study consisted of ten procedures on cadaver wrists followed by dissection to analyse the effectiveness of the retinaculum release and detect any collateral damage. The second part was a prospective clinical study of 35 procedures. Outcomes were evaluated through a 6-month clinical follow-up and telephone interview at the end of the study. The following parameters were monitored over time: pain level on a visual analogue scale, the QuickDASH and the PRWE. Patient satisfaction questionnaires were also administered. RESULTS: No complications were found during the cadaver study. However, the release was confirmed as 'partial' in all wrists. In the clinical portion of this study, significant improvement was observed in 91.4 % of cases (32/35) within 1 month and the results were stable until the end of the study; all of these patients avoided surgery. The release procedure failed in three patients who eventually required surgical treatment. CONCLUSION: US-guided partial release and simultaneous corticosteroid injection for treatment of de Quervain's disease using a 21-gauge needle is feasible in current practice, with minimal complications.

Item Type:Article
HAL Id:hal-02135110
Audience (journal):International peer-reviewed journal
Uncontrolled Keywords:
Institution:Université de Toulouse > Université Toulouse III - Paul Sabatier - UT3 (FRANCE)
Other partners > Clinique Médipôle Garonne (FRANCE)
Other partners > Faculté de médecine du CNHU de Cotonou (BENIN)
Other partners > Centre Hospitalier Universitaire de Toulouse - CHU Toulouse (FRANCE)
Other partners > Polyclinique Le Languedoc (FRANCE)
Statistics:download
Deposited On:03 Apr 2019 07:17

Repository Staff Only: item control page